Representing estates and facilities professionals operating within the  
 
 

News

 
17
Jul

BTG forced to halt cancer treatment


Healthcare group BTG has been forced to halt production of one of its cancer treatments following a warning letter from regulators in the US, The Guardian reports.

Healthcare group BTG has been forced to halt production of one of its cancer treatments following a warning letter from regulators in the US, The Guardian reports.

The FDA has raised concerns about BTG’s brachytherapy products and BTG in response said: “We are working to identify and implement processes and procedures to address these concerns.”

BTG voluntarily closed the facility to rectify the problems, with management believing this is a case of the facility playing catch-up to new regulations rather than a larger issue.

Archive